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that introduce 15%-30% dose differences compared with all-
water dosimetry. A TG43 dose rate calculation method is 
presented that includes silastic and Modulay heterogeneous 
effects, uses the actual plaque seed configuration, is not 
restricted to a particular commercial treatment planning 
system, and does not require purchase of additional 
software.  
Materials and Methods: Dose rate is calculated using TG43 
formalism: DoseEP(r, θ)= SkΛ[GL(r,θ)/GL(r0,θ0)]gEP(r)FEP(r,θ), 
with revised radial dose, gEP(r), and anisotropy, FEP(r,θ), 
functions specific to I-125 or Pd-103 seeds in COMS eye 
plaques. EP signifies that the functions are specific to COMS 
eye plaques. gEP(r), is obtained from Monte Carlo data for eye 
plaques that contain just a single center seed. FEP(r,θ) is 
obtained by performing a Nelder-Mead Simplex routine to 
find a least squares solution that minimizes differences 
between Monte Carlo dose rate and DoseEP(r, θ). 
Figure: EP method calculation accuracy over the inner sclera 
surface for 10 mm and 22 mm COMS eye plaques. Dose rate 
for each curve is normalized to the value at central axis. 
 
 
Results: TG43 formalism calculations agree with Monte Carlo 
results, for 10 mm though 22 mm I-125 and Pd-103 eye 
plaques, to within 2% along and near the plaque central axis 
and within 4% in the penumbra region for depths ≥ 1 mm. 
Methods and data for calculating dose rate for COMS plaques 
with seed model other than I-125 Model 6711 and Pd-103 
Model 200 are provided. Since actual seed configurations are 
used in dose rate calculations, this formalism may also be 
used to estimate dosimetry for non-standard seed loadings. 
Conclusions: This manuscript enables the clinical user to 
perform accurate heterogeneity-corrected dose rate 
calculations for COMS eye plaques using TG43 formalism in a 
spreadsheet or commercial treatment planning system that 
has a TG43 line source geometry function calculation 
capabilities.  
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Purpose/Objective: The quality of radiotherapy treatment 
can be increased by visualising the tumour volume during 
irradiation. This is achieved by means of an MRI-Linac, which 
combines patient irradiation and real-time treatment 
guidance with excellent soft-tissue contrast. Within an EMRP 
Joint Research Project [1], we are currently investigating 
whether interaction cross sections used in Monte Carlo codes 
for the simulation of low-energy secondary electron transport 
require modification owing to the presence of a magnetic 
field. For this purpose, the calculated differential cross 
sections (DCS) for electron scattering with and without 
magnetic field were compared. 
Materials and Methods: Since water molecules are 
diamagnetic, they can be expected to partially orient 
themselves under the influence of an external magnetic 
field. This is because the overall energy of the water 
molecules depends on the relative orientation of the 
molecule with respect to the magnetic field. The orientation 
of a single water molecule was defined using the Euler angles 
(α,β,γ), which describe a sequence of rotations around two 
perpendicular axes. A data set of DCS for elastic scattering 
and ionisation was computed for various values of the Euler 
angles from 0° to 360° and incident energies varying between 
50 eV and 1 keV. The influence of an external magnetic field 
was then taken into account by determining the resulting 
distribution of the fractional number of molecules having a 
certain orientation. This distribution was used together with 
the aforementioned data set in order to calculate the mean 
values of the DCS in presence of a magnetic field. 
Results: The values of the mean DCS in presence of magnetic 
field were compared to those with zero field. For 1.5 T, only 
minor discrepancies of about 7 x10-8 and 1x10-9 were found 
for elastic scattering and ionisation respectively. 
Conclusions: The results show no significant influence of the 
magnetic field in the range corresponding to MRI-linac 
devices. Consequently, no changes are necessary in the DCS 
data used by Monte Carlo simulation codes for dose 
calculation. 
[1] The EMRP is jointly funded by the EMRP participating 
countries within EURAMET and the European Union. 
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Purpose/Objective: In many cases treatments to the chest 
wall require complete skin coverage, specifically for patients 
with stage pT4 disease or with infiltrating carcinoma. Helical 
Tomotherapy makes it possible to create treatment plans 
that deliver higher doses to the skin in comparison with other 
treatments (3D and fixed-gantry IMRT treatments), even 
without the use of bolus. This work aimed to evaluate, by 
means of Gafchromic EBT3 films (ISP® Corporation), the skin 
dose given to patients with chest wall carcinoma undergoing 
adjuvant tomohelical treatments with and without bolus and 
also using a virtual bolus, which makes it possible to 
compensate a potential under-coverage due to breathing 
motion. 
Materials and Methods: The study was conducted on a 
Tomotherapy Hi-Art® System (Accuray®, Sunnyvale, CA). 
First of all, standard treatment plans (2Gy/fr) were 
optimized using the TomoTherapy TPS (Version 4.2.2) and 
delivered to an anthropomorphic phantom (RANDO® 
Phantom), which had previously been scanned (slice 
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thickness; 2.5cm). The skin dose was measured using EBT 
films (read with an Epson Expression Scanner 10000 XL and 
processed with the FilmQAProTM application considering the 
average dose in a ROI) and then compared with the TPS-
calculated average dose in a 3mm thick superficial VOI. The 
plans with virtual bolus were optimized by extending the 
original PTVs outside the body by 5 mm. Two scenarios were 
considered: in the first case a unit density override was 
applied to the PTV, while in the second one the original 
density was considered. The following comparisons were 
performed: measured and TPS-calculated dose with/without 
bolus and virtual bolus; measured dose with/without bolus. 
Results: The mean difference (mean% ± SD%) between 
measured and TPS-calculated dose, in the cases with/without 
bolus, was 16.0% ± 8.0% and 35.7% ± 6.2% respectively. In the 
case of virtual bolus it was 42.4% ± 5.7% (density override; 1) 
and 24.6% ± 7.9% (original density). The mean difference 
(mean% ± SD%) between bolus and no bolus measured dose 
was 15.9% ± 5.4% (p<0.05; t-Student test). 
Conclusions: Although the superficial dose is higher with 
tomohelical treatments than with 3D and fixed-gantry IMRT 
treatments, tissue equivalent bolus should be used if the 
prescribed dose is required to the skin. A better coverage of 
the target may also be obtained using virtual bolus by 
extending the PTV outside the skin, in order to consider 
breathing motion. These preliminary results show that the 
TPS overestimates dose in the build-up region because of the 
inaccuracy of the calculation algorithm in the superficial 
millimeters of skin. Gafchromic EBT3 films are adequate 
instruments for future 'in vivo' skin dose measurements in 
patients with pT4 or infiltrating chest wall carcinoma, as the 
TPS does not give accurate dose values at the surface  
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Purpose/Objective: In order to configure and test a new 
treatment planning system (TPS), clinical physicists are often 
required to obtain dosimetric datasets for small radiation 
fields. During the commissioning process, data entered within 
a TPS should describe the unperturbed dose distribution in 
water as accurately as possible. However, as lateral 
electronic equilibrium breaks down, so does the ability of a 
detector with non-unit density to provide a good surrogate 
for water dose. The research community has investigated this 
issue via the calculation of correction factors to account for 
perturbations introduced by dosimeters within small fields. 
However, the practicability of correction factors within 
clinical commissioning is yet to be clarified. This 
experimental work investigates the magnitude and potential 
impact of correction factors relevant to linac commissioning. 
Materials and Methods: We commissioned two different 
treatment planning systems – Varian's Eclipse and BrainLab's 
iPlan – for a Novalis TrueBeam STX with four beam energies: 
6FFF, 6MV, 10FFF and 10MV. For fields defined by both jaws 
and MLCs (side-lengths ≥ 5mm) we measured datasets using 
three detectors: PTW electron diode 60017 (Ediode), PTW 
microDiamond 60019 (μDiamond) and Standard Imaging 
Scintillator W1. Ashland EBT3 film was used as an 
experimental gold-standard to calculate correction factors 
for the three detectors. 
Results: The scintillator was found to be the best performing 
detector: its on-axis EBT3 correction factors were 
approximately unity for all field sizes and beam energies. 
This result enabled us to use the scintillator as an alternative 
gold standard, reducing experiment time compared to EBT3. 
Good agreement was obtained between the μDiamond and 
Ediode, but both read high relative to the scintillator and 
EBT3. Additionally, for the Ediode a dose-rate dependence 
was observed and its known over-response to low energy 
scatter within large fields was found to be enhanced for 6FFF 
beams relative to 6MV. For the Ediode and μDiamond small to 
large field measurement factor (MF) perturbations are 
plotted in the figure. For a 10mm field the μDiamond 
introduces output factor errors of ~1.5% for 6 MV beams and 
2.5% for 10 MV. 
 
Conclusions: No correction factors are required if the W1 
Scintillator is used to measure small field commissioning 
data. However, this instrument has not yet been fully 
integrated with a scanning water tank, limiting its utility for 
profile and PDD measurement. For centres without access to 
a W1, the μDiamond is recommended over the Ediode. 
Obtaining correction factors using EBT3 is a time-consuming 
and difficult task. At 6 MV and 10 MV the uncorrected 
μDiamond will give results accurate to within 2% for MLC-
defined field sizes above ~10mm and ~15mm respectively, 
such that correction factors may not be required. However, if 
smaller fields are to be utilised or greater accuracy is 
required then correction factors should be applied. 
 
 
 
 
 
